Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
RELX
RELX
$61.8B
| $841K | ﹤0.01% |
24,962
+1,581
| +7% | +$52.2K |
|
2577
CALL
Zoom
ZM
$28.2B
| $839K | ﹤0.01% |
12,000
| – | – |
|
2578
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
| $839K | ﹤0.01% |
25,423
+20,858
| +457% | +$726K |
|
2579
Alamo Group
ALG
$1.94B
| $833K | ﹤0.01% |
4,820
-3,739
| -44% | -$670K |
|
|
SCPL
2580
CALL
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $831K | ﹤0.01% |
36,500
| – | – |
|
|
IRBT
2581
DELISTED
iRobot
IRBT
| $830K | ﹤0.01% |
21,899
-34,212
| -61% | -$1.37M |
|
|
ALEX
2582
DELISTED
Alexander & Baldwin
ALEX
| $829K | ﹤0.01% |
49,559
-26,033
| -34% | -$472K |
|
2583
Turkcell
TKC
$4.68B
| $828K | ﹤0.01% |
175,121
+19,996
| +13% | +$95.3K |
|
2584
Donnelley Financial Solutions
DFIN
$1.16B
| $827K | ﹤0.01% |
14,698
-6,996
| -32% | -$340K |
|
2585
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $825K | ﹤0.01% |
28,000
| – | – |
|
2586
Dana Inc
DAN
$2.9B
| $824K | ﹤0.01% |
56,162
-42,796
| -43% | -$713K |
|
2587
iShares MSCI Saudi Arabia ETF
KSA
$623M
| $824K | ﹤0.01% |
21,259
-192,105
| -90% | -$7.84M |
|
2588
CALL
Regenxbio
RGNX
$620M
| $823K | ﹤0.01% |
50,000
+25,100
| +101% | +$455K |
|
|
2589
PUT
Regenxbio
RGNX
$620M
| $823K | ﹤0.01% |
50,000
+25,100
| +101% | +$455K |
|
2590
PUT
Cummins
CMI
$87.5B
| $822K | ﹤0.01% |
+3,600
| New | +$869K |
|
2591
Global X FinTech ETF
FINX
$170M
| $820K | ﹤0.01% |
40,732
-13,363
| -25% | -$296K |
|
2592
CALL
Corcept Therapeutics
CORT
$12.4B
| $817K | ﹤0.01% |
30,000
-20,400
| -40% | -$590K |
|
|
2593
PUT
Corcept Therapeutics
CORT
$12.4B
| $817K | ﹤0.01% |
30,000
-20,400
| -40% | -$590K |
|
|
VSTO
2594
DELISTED
Vista Outdoor Inc.
VSTO
| $817K | ﹤0.01% |
24,671
-16,545
| -40% | -$488K |
|
2595
Stride
LRN
$3.41B
| $813K | ﹤0.01% |
18,049
-24,578
| -58% | -$1,000K |
|
2596
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
| $809K | ﹤0.01% |
9,253
| – | – |
|
2597
CALL
NovoCure
NVCR
$1.73B
| $808K | ﹤0.01% |
50,000
-429,000
| -90% | -$12.4M |
|
2598
Oil States International
OIS
$489M
| $805K | ﹤0.01% |
96,164
+31,306
| +48% | +$254K |
|
2599
Harmony Biosciences
HRMY
$2.04B
| $802K | ﹤0.01% |
24,482
-8,167
| -25% | -$284K |
|
2600
Cogent Biosciences
COGT
$6.65B
| $802K | ﹤0.01% |
82,241
+2,522
| +3% | +$29.9K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.